Author:
Yang Libo,Lu Dongli,Lai Yutian,Shen Mengjia,Yu Qiuxiao,Lei Ting,Pu Tianjie,Bu Hong
Funder
1.3.5 project for disciplines of excellence
Publisher
Springer Science and Business Media LLC
Reference55 articles.
1. Elshof LE, Schaapveld M, Rutgers EJ, et al. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study. Breast Cancer Res. 2017;19(1):26.
2. Olivotto IA, Bancej C, Goel V, et al. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ. 2001;165(3):277–83.
3. Armed Forces Health Surveillance Center. Incident diagnoses of breast cancer, active component service women, U.S. Armed Forces, 2000–2012. MSMR. 2013;20(9):25–7.
4. Oseni TO, Zhang B, Coopey SB, Gadd MA, Hughes KS, Chang DC. Twenty-five year trends in the incidence of ductal carcinoma in situ in US Women. J Am Coll Surg. 2019;228(6):932–9.
5. van Seijen M, Lips EH, Thompson AM, et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. Br J Cancer. 2019;121(4):285–92.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献